Lacosamide Injection
Product Images NDC 83090-012

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 83090-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sintetica Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Lacosamide 014)

``` Proportion of Patients Figure 3 - Kaplan-Meier Analysis of Time to 21 PGTC Seizure (Study 5) Analysis Set: Modified Full Analysis Set Statistical data indicates a significant reduction in the occurrence of seizures for patients in the treatment group compared to the placebo group. The analysis shows a 52% reduction in seizure frequency with the medication PR 540. The chart displays a comparative analysis of the time taken for patients to experience 21 PGTC seizures between the two groups.```*

FDA Label Image

Principal Display Panel (20 mL vial carton)

FDA Label Image

Chemical Structure (Lacosamideinjection 011)

FDA Label Image

Figure 1 (Lacosamideinjection 012)

FDA Label Image

Figure 2 (Lacosamideinjection 013)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.